Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 35,982 $ 14,508
Short-term investments 49,729 0
Prepaid expenses and other current assets 4,502 6,904
Current portion of restricted cash   60
Total current assets 90,213 21,472
Property and equipment, net 138 421
Restricted cash, less current portion 64 248
Other assets 8,007 10,651
Total assets 98,422 32,792
Current liabilities:    
Accounts payable 276 816
Accrued expenses 1,690 1,829
Derivative liability 9,183 28,865
Current portion of long-term debt 3,244 6,374
Current portion of royalty-linked notes   114
Income taxes payable 141 102
Other current liabilities 3,295 3,598
Total current liabilities 17,829 41,698
Long-term debt, less current portion 6,134 22,462
Long-term royalty-linked notes, less current portion 18,403 13,389
Other liabilities 3,608 5,802
Total liabilities 45,974 83,351
Commitments and contingencies (Note 14)
Shareholders’ equity / (deficit):    
Undesignated preferred shares, $0.01 par value per share: 100,000,000 shares authorized at September 30, 2021 and December 31, 2020; no shares issued at September 30, 2021 and December 31, 2020
Ordinary shares, $0.01 par value per share: 300,000,000 shares authorized, 182,775,282 shares issued at September 30, 2021; 150,000,000 shares authorized, 49,431,028 shares issued at December 31, 2020 1,827 494
Additional paid-in capital 424,932 235,876
Accumulated deficit (374,311) (286,929)
Total shareholders' equity / (deficit) 52,448 (50,559)
Total liabilities and shareholders’ equity / (deficit) $ 98,422 $ 32,792